Food and Drug Administration (FDA) has approved the use of L-carnitine as a complementary treatment for individuals with serious kidney disease who are undergoing hemodialysis, albeit, delivered intravenously
Some patients, especially those on long-term or high-dose B12 treatment, may develop complications like: 1
10.2337/db06-0399 138 YamamotoK.TakaharaK.OyadomariS.OkadaT.SatoT.HaradaA.et al (2010)
At Cenexa Labs, we manufacture our own peptides under strict USA-based standardsright here IN THE USA
Russian clinical trials have contributed valuable data, but methodological differences, including smaller sample sizes, different statistical approaches, and less rigorous blinding procedures compared to FDA standards, mean that Western regulatory agencies generally do not accept this data for drug approval
The therapeutic potential of carnosine: Focus on cellular and molecular mechanisms